Navigate the shift from 21 CFR Part 820 to the FDA QMSR with a structured, risk-based approach that ensures compliance and strengthens your quality system.
Navigate the transition from the FDA Quality System Regulation (21 CFR Part 820) to the FDA Quality Management System Regulation (QMSR) with a structured, risk-based approach designed to ensure compliance, minimize disruption, and strengthen quality system effectiveness.
This service provides comprehensive support for organizations transitioning from legacy QSR requirements to the FDA QMSR framework aligned with ISO 13485. Through detailed gap assessments, process reviews, and implementation support, we identify areas requiring updates across procedures, documentation, quality processes, and operational controls. The transition program focuses not only on regulatory alignment but also on practical implementation to ensure sustainable compliance and audit readiness.
Gap findings are prioritized based on compliance risk and operational impact, enabling focused remediation and efficient resource planning. Teams receive expert guidance on interpreting QMSR requirements, updating documentation, and implementing system improvements to support a smooth and confident transition.
Expert-led QMSR transition that delivers compliance confidence from day one
Thorough assessment of QSR-to-QMSR compliance gaps across your entire quality system
Procedures, SOPs, and QMS records updated to meet QMSR and ISO 13485 expectations
Regulatory guidance on QMSR requirements to ensure correct and practical implementation
Transition completed with full audit readiness for future FDA inspections under QMSR